ICM
AMN icon

Invenomic Capital Management’s AMN Healthcare AMN Stock Holding History

Invenomic Capital Management’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-401,248
Closed -$9.81M – 152
2025
Q1 		$9.81M Sell
401,248
-559
-0.1% -$14.4K 0.5% 73
2024
Q4 		$9.61M Buy
401,807
+322,445
+406% +$10.2M 0.46% 69
2024
Q3 		$3.36M Sell
79,362
-208,030
-72% -$10.9M 0.18% 120
2024
Q2 		$14.7M Buy
287,392
+96,468
+51% +$5.47M 0.72% 46
2024
Q1 		$11.9M Buy
+190,924
New +$13M 0.63% 57

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invenomic Capital Management's AMN Position: Q2 2025 in Review

Invenomic Capital Management sold out of AMN Healthcare (AMN) in Q2 2025, closing a stake of 401,248 shares — an estimated $9.81M sold.

Invenomic Capital Management first reported a position in AMN in Q1 2024 and held it in 5 quarters. The position peaked at $14.7M in Q2 2024. 248 funds tracked by Wall St. Rank hold AMN as of Q2 2025.

  • Invenomic Capital Management reported no remaining AMN Healthcare position as of Q2 2025 after selling out during the quarter.
  • Invenomic Capital Management sold 401,248 AMN Healthcare shares in Q2 2025, an estimated $9.81M.
  • Invenomic Capital Management first reported a position in AMN Healthcare in Q1 2024 and held it in 5 quarters.
  • Invenomic Capital Management's AMN Healthcare position peaked at $14.7M in Q2 2024.
  • 248 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2025.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.